PETNet, Blue Earth ink prostate PET agent deal

By staff writers

May 21, 2015 -- Siemens Healthcare subsidiary PETNet Solutions has inked an agreement with Blue Earth Diagnostics for the exclusive manufacturing and distribution of a radiopharmaceutical for PET/CT scans.

Clinical trials for F-18 fluciclovine are underway in the U.S., Japan, Italy, Norway, Sweden, and Finland, PETNet Solutions said. The tracer's long half-life may make supplying it to clinical trial sites and imaging centers easier, once it gains approval from the U.S. Food and Drug Administration (FDA), according to the firm.

Copyright © 2015

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking